Daan Gene Balance Sheet Health
Financial Health criteria checks 5/6
Daan Gene has a total shareholder equity of CN¥8.8B and total debt of CN¥326.6M, which brings its debt-to-equity ratio to 3.7%. Its total assets and total liabilities are CN¥10.4B and CN¥1.6B respectively.
Key information
3.7%
Debt to equity ratio
CN¥326.57m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥826.27m |
| Equity | CN¥8.80b |
| Total liabilities | CN¥1.58b |
| Total assets | CN¥10.37b |
Recent financial health updates
Recent updates
Is Daan Gene (SZSE:002030) Weighed On By Its Debt Load?
May 02
Daan Gene's (SZSE:002030) Shareholders Have More To Worry About Than Only Soft Earnings
Apr 05Calculating The Fair Value Of Daan Gene Co., Ltd. (SZSE:002030)
Mar 25Daan Gene Co., Ltd. (SZSE:002030) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Mar 06Financial Position Analysis
Short Term Liabilities: 002030's short term assets (CN¥5.5B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 002030's short term assets (CN¥5.5B) exceed its long term liabilities (CN¥108.1M).
Debt to Equity History and Analysis
Debt Level: 002030 has more cash than its total debt.
Reducing Debt: 002030's debt to equity ratio has reduced from 40% to 3.7% over the past 5 years.
Debt Coverage: 002030's debt is well covered by operating cash flow (321.8%).
Interest Coverage: Insufficient data to determine if 002030's interest payments on its debt are well covered by EBIT.